Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aarhus University Hospital | OTHER |
| Biogen | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate underlying mechanisms possibly explaining the beneficial effects of progressive resistance training for people with multiple sclerosis.
Exercise in general, and progressive resistance training (PRT) in particular, is regarded as an important tool in the rehabilitation of people with multiple sclerosis (MS).
Previous studies have reported positive effects of PRT on muscle strength, functional capacity, fatigue and quality of life. Also, a possible disease modifying effect has been proposed. However, the underlying physiological mechanisms that might explain these beneficial effects and the possible effects on disease progression are unresolved. Additionally, none of the previous studies has been concerned with the possible impact of MS progression type, gender and/or medication.
The purpose of this randomized, controlled, gender stratified trial is to investigate underlying mechanisms possibly explaining the beneficial effects of progressive resistance training for people with multiple sclerosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Training | Experimental |
| |
| Control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Training | Behavioral | Bi-weekly progressive resistance training |
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood-borne biomarkers | Resting levels of bloodbourne biomarkers;
| Change from baseline to 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Neuro-muscular function of knee extensors | By use of an isokinetic dynamometer, EMG and stimulation equipment the following will be assessed for the knee extensors;
| Change from baseline to 24 weeks |
| Walking performance |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tue Kjølhede, M.Sc. | Sport Science, Department of Public Health, Aarhus University | Principal Investigator |
| Ulrik Dalgas, Ph.D. | Sport Science, Department of Public Health, Aarhus University | Study Chair |
| Kristian Vissing, Ph.D. | Sport Science, Department of Public Health, Aarhus University | Study Chair |
| Thor Petersen, Dr.med | MS Clinic, Department of Neurology, Aarhus University Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MS Clinic, Department of Neurology, Aarhus University Hospital | Aarhus C | 8000 | Denmark | |||
| Sport Science, Aarhus University |
Not provided
| ID | Term |
|---|---|
| D020529 | Multiple Sclerosis, Relapsing-Remitting |
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Walking performance will be assessed by the;
|
| Change from baseline to 24 weeks |
| Self-reported measures | The self-reported measures contains questionnaires regarding;
| Change from baseline to 24 weeks |
| Brain volume | MRI-scans of the head will provide the following measurements;
| Change from baseline to 24 weeks |
| Body Composition | Weight and Bodyfat-% will be assessed with a Bodycomposition weight (Tanita SC220) | Change from baseline to 24 weeks |
| Thigh muscle cross-sectional area | MRI-scans of the thigh will provide cross-sectional area of
| Change from baseline to 24 weeks |
| Aarhus C |
| 8000 |
| Denmark |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |